Raymond James Financial
FTXH icon

Raymond James Financial’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Raymond James Financial’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
54,968
+43,249
+369% +$1.51M ﹤0.01% 3447
2026
Q1 		$403K Buy
+11,719
New +$400K ﹤0.01% 4492
2025
Q3 		– Sell
-2,225
Closed -$57K – 5622
2025
Q2 		$57K Buy
+2,225
New +$56.3K ﹤0.01% 5138

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Raymond James Financial's FTXH Position: Q2 2026 in Review

Raymond James Financial increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 369% in Q2 2026, buying an estimated $1.51M and bringing the position to 54,968 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3447.

Raymond James Financial first reported a position in FTXH in Q2 2025 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Raymond James Financial held 54,968 shares of First Trust Nasdaq Pharmaceuticals ETF worth $2.1M as of Q2 2026.
  • Raymond James Financial bought 43,249 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $1.51M.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3447 holding.
  • Raymond James Financial first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2025 and has held it in 3 quarters since.
  • 30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.